Cipla Recalls 6 Batches Of Bronchospasm Treatment Inhalation Aerosol In US
NDTV
Out of an abundance of precaution, Cipla further said the specified six batches manufactured using the same lot of valves are being recalled.
Pharmaceutical firm Cipla Ltd on Friday said it is voluntarily recalling six batches of Albuterol Sulfate inhalation aerosol in the US market due to container defect.
The company's wholly-owned subsidiary, Cipla USA Inc, is voluntarily recalling the six batches of Albuterol Sulfate inhalation Aerosol 90 mcg, manufactured in November 2021, to the consumer level, Cipla Ltd said in a regulatory filing.
"The company is initiating a recall in the US due to a market complaint for one single inhaler (batch number - IB20056), where leakage was observed through the inhaler valve," it said.
More Related News